Peripheral blood monocyte count as an aid in optimizing progenitor collection in children

Pediatric Blood & Cancer
Caron Strahlendorf, Grace Chan

Abstract

CD34 enumeration, although established as the gold standard for timing peripheral blood progenitor cell harvests, is not always available. We investigated whether the peripheral blood monocyte population could be used to assist in predicting the peak of circulating progenitors for harvesting autologous blood stem cells in children. A retrospective analysis was done on 140 harvests in 40 patients. Cross-tabulation analysis of peripheral blood CD34 counts and monocyte counts showed a good correlation. We conclude that in the absence of CD34 results, the monocyte count gives a good indication of early marrow regeneration and helps in predicting optimal time for harvest.

Citations

May 14, 2005·Journal of Clinical Apheresis·Caron Strahlendorf
Apr 26, 2012·Journal of Clinical Apheresis·Shen-Miao YangKai-Yan Liu
Aug 8, 2019·Journal of Clinical Apheresis·Tony H TruongVictor A Lewis
Dec 4, 2020·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Nidhi SharmaSantanu Sen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.